Gepirone Hydrochloride

CHEMBL1204187 Phase 4 已批准 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

395.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of gepirone with the same therapeutic properties. This partial agonist at serotonin 5-HT1A receptors is used to treat generalized anxiety disorder and major depressive disorder.

分子量

395.9000 g/mol

TPSA

69.60 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1.Cl

InChI

InChI=1S/C19H29N5O2.ClH/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18;/h5-7H,3-4,8-15H2,1-2H3;1H

Molecular Formula

C19H30ClN5O2

HBD / HBA

1 / 6

可旋转键数

6

重原子数

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A hydrochloride salt form of gepirone with the same therapeutic properties. This partial agonist at serotonin 5-HT1A receptors is used to treat generalized anxiety disorder and major depressive disorder.

Yes, Gepirone Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1204187. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 55190. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

正在寻找患者友好型信息？

Gepirone Hydrochloride 在 PillFYI 上

结构

快速数据

分子式: C19H30ClN5O2

外部链接

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.